Antiproliferative effects of some novel synthetic solanidine analogs on HL-60 human leukemia cells in vitro

Renáta Minorics, Thomas Szekeres, Georg Krupitza, Philipp Saiko, Benedikt Giessrigl, J. Wölfling, E. Frank, I. Zupkó

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

There is increasing evidence of the direct antiproliferative effects of various steroidal structures, including cardenolides, steroidal alkaloids and sexual hormones. The aim of the present study was to characterize the antiproliferative effects of three synthetic solanidine analogs (1-3) on HL-60 human leukemia cells. The three compounds exerted similar cytostatic effects (IC50 values: 1.27-2.94 μM after a 72-h exposure) and the most effective (2) was selected for further investigations. Incubation with compound 2 resulted in a marked chromatin condensation followed by a gradual increase in cell membrane permeability detected by Hoechst dye 33258-propidium iodide double staining. A flow cytometric analysis revealed a marked decrease in the G1 phase and substantial increases in the S and G2/M phases after 24-h incubation, while after 48 h the proportion of cells in the subG1 phase was increased significantly with a concomitant decrease in cells in the G1 and G2/M phases. Compound 2 at 6.0 μM significantly decreased the activity of ribonucleotide reductase and proved to be a potent antioxidant in the lipid peroxidation and DPPH assays (IC50 values: 2.0 and 13.1 μM, respectively). The antiproliferative effect of the test compound on the non-cancerous human lung fibroblast cell line (MRC-5) was significantly weaker than that on the leukemia cells. These results lead to the conclusion that compound 2 induces a marked disturbance in the cell cycle, which is, at least partially, a consequence of the inhibition of DNA synthesis.

Original languageEnglish
Pages (from-to)156-162
Number of pages7
JournalSteroids
Volume76
Issue number1-2
DOIs
Publication statusPublished - Jan 2011

Fingerprint

Leukemia
Cardenolides
Cells
Ribonucleotide Reductases
Propidium
G2 Phase
Cytostatic Agents
Fibroblasts
Cell membranes
Alkaloids
Cell Division
Inhibitory Concentration 50
Chromatin
Condensation
Assays
Coloring Agents
Antioxidants
Hormones
Cell Membrane Permeability
Bisbenzimidazole

Keywords

  • Antiproliferative effect
  • Cell cycle arrest
  • Ribonucleotide reductase
  • Solanidine
  • Steroidal compound

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Molecular Biology
  • Organic Chemistry
  • Pharmacology

Cite this

Antiproliferative effects of some novel synthetic solanidine analogs on HL-60 human leukemia cells in vitro. / Minorics, Renáta; Szekeres, Thomas; Krupitza, Georg; Saiko, Philipp; Giessrigl, Benedikt; Wölfling, J.; Frank, E.; Zupkó, I.

In: Steroids, Vol. 76, No. 1-2, 01.2011, p. 156-162.

Research output: Contribution to journalArticle

Minorics, Renáta ; Szekeres, Thomas ; Krupitza, Georg ; Saiko, Philipp ; Giessrigl, Benedikt ; Wölfling, J. ; Frank, E. ; Zupkó, I. / Antiproliferative effects of some novel synthetic solanidine analogs on HL-60 human leukemia cells in vitro. In: Steroids. 2011 ; Vol. 76, No. 1-2. pp. 156-162.
@article{9e8175d879a94170afac68a58e2a50e7,
title = "Antiproliferative effects of some novel synthetic solanidine analogs on HL-60 human leukemia cells in vitro",
abstract = "There is increasing evidence of the direct antiproliferative effects of various steroidal structures, including cardenolides, steroidal alkaloids and sexual hormones. The aim of the present study was to characterize the antiproliferative effects of three synthetic solanidine analogs (1-3) on HL-60 human leukemia cells. The three compounds exerted similar cytostatic effects (IC50 values: 1.27-2.94 μM after a 72-h exposure) and the most effective (2) was selected for further investigations. Incubation with compound 2 resulted in a marked chromatin condensation followed by a gradual increase in cell membrane permeability detected by Hoechst dye 33258-propidium iodide double staining. A flow cytometric analysis revealed a marked decrease in the G1 phase and substantial increases in the S and G2/M phases after 24-h incubation, while after 48 h the proportion of cells in the subG1 phase was increased significantly with a concomitant decrease in cells in the G1 and G2/M phases. Compound 2 at 6.0 μM significantly decreased the activity of ribonucleotide reductase and proved to be a potent antioxidant in the lipid peroxidation and DPPH assays (IC50 values: 2.0 and 13.1 μM, respectively). The antiproliferative effect of the test compound on the non-cancerous human lung fibroblast cell line (MRC-5) was significantly weaker than that on the leukemia cells. These results lead to the conclusion that compound 2 induces a marked disturbance in the cell cycle, which is, at least partially, a consequence of the inhibition of DNA synthesis.",
keywords = "Antiproliferative effect, Cell cycle arrest, Ribonucleotide reductase, Solanidine, Steroidal compound",
author = "Ren{\'a}ta Minorics and Thomas Szekeres and Georg Krupitza and Philipp Saiko and Benedikt Giessrigl and J. W{\"o}lfling and E. Frank and I. Zupk{\'o}",
year = "2011",
month = "1",
doi = "10.1016/j.steroids.2010.10.006",
language = "English",
volume = "76",
pages = "156--162",
journal = "Steroids",
issn = "0039-128X",
publisher = "Elsevier Inc.",
number = "1-2",

}

TY - JOUR

T1 - Antiproliferative effects of some novel synthetic solanidine analogs on HL-60 human leukemia cells in vitro

AU - Minorics, Renáta

AU - Szekeres, Thomas

AU - Krupitza, Georg

AU - Saiko, Philipp

AU - Giessrigl, Benedikt

AU - Wölfling, J.

AU - Frank, E.

AU - Zupkó, I.

PY - 2011/1

Y1 - 2011/1

N2 - There is increasing evidence of the direct antiproliferative effects of various steroidal structures, including cardenolides, steroidal alkaloids and sexual hormones. The aim of the present study was to characterize the antiproliferative effects of three synthetic solanidine analogs (1-3) on HL-60 human leukemia cells. The three compounds exerted similar cytostatic effects (IC50 values: 1.27-2.94 μM after a 72-h exposure) and the most effective (2) was selected for further investigations. Incubation with compound 2 resulted in a marked chromatin condensation followed by a gradual increase in cell membrane permeability detected by Hoechst dye 33258-propidium iodide double staining. A flow cytometric analysis revealed a marked decrease in the G1 phase and substantial increases in the S and G2/M phases after 24-h incubation, while after 48 h the proportion of cells in the subG1 phase was increased significantly with a concomitant decrease in cells in the G1 and G2/M phases. Compound 2 at 6.0 μM significantly decreased the activity of ribonucleotide reductase and proved to be a potent antioxidant in the lipid peroxidation and DPPH assays (IC50 values: 2.0 and 13.1 μM, respectively). The antiproliferative effect of the test compound on the non-cancerous human lung fibroblast cell line (MRC-5) was significantly weaker than that on the leukemia cells. These results lead to the conclusion that compound 2 induces a marked disturbance in the cell cycle, which is, at least partially, a consequence of the inhibition of DNA synthesis.

AB - There is increasing evidence of the direct antiproliferative effects of various steroidal structures, including cardenolides, steroidal alkaloids and sexual hormones. The aim of the present study was to characterize the antiproliferative effects of three synthetic solanidine analogs (1-3) on HL-60 human leukemia cells. The three compounds exerted similar cytostatic effects (IC50 values: 1.27-2.94 μM after a 72-h exposure) and the most effective (2) was selected for further investigations. Incubation with compound 2 resulted in a marked chromatin condensation followed by a gradual increase in cell membrane permeability detected by Hoechst dye 33258-propidium iodide double staining. A flow cytometric analysis revealed a marked decrease in the G1 phase and substantial increases in the S and G2/M phases after 24-h incubation, while after 48 h the proportion of cells in the subG1 phase was increased significantly with a concomitant decrease in cells in the G1 and G2/M phases. Compound 2 at 6.0 μM significantly decreased the activity of ribonucleotide reductase and proved to be a potent antioxidant in the lipid peroxidation and DPPH assays (IC50 values: 2.0 and 13.1 μM, respectively). The antiproliferative effect of the test compound on the non-cancerous human lung fibroblast cell line (MRC-5) was significantly weaker than that on the leukemia cells. These results lead to the conclusion that compound 2 induces a marked disturbance in the cell cycle, which is, at least partially, a consequence of the inhibition of DNA synthesis.

KW - Antiproliferative effect

KW - Cell cycle arrest

KW - Ribonucleotide reductase

KW - Solanidine

KW - Steroidal compound

UR - http://www.scopus.com/inward/record.url?scp=78650509902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650509902&partnerID=8YFLogxK

U2 - 10.1016/j.steroids.2010.10.006

DO - 10.1016/j.steroids.2010.10.006

M3 - Article

C2 - 20974162

AN - SCOPUS:78650509902

VL - 76

SP - 156

EP - 162

JO - Steroids

JF - Steroids

SN - 0039-128X

IS - 1-2

ER -